Protara Therapeutics Revenue
Biotechnology Research • 
Manhattan, New York, United States • 21-50 Employees
Protara Therapeutics revenue & valuation
| Annual revenue | $2,948,000 |
| Revenue per employee | $61,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $9,500,000 |
| Total funding | $145,000,000 |
Key Contacts at Protara Therapeutics
Jacqueline Zummo
Co-Founder & Chief Scientific Operations Officer
Leslie Ruhno Grimes
Senior Director, Clinical Operations
Jesse Shefferman
Chief Executive Officer
Barry Flannelly
Member Board Of Directors
Michael Shim
Associate Director, Medical Science Liaison
Karen Lee Errigo
Associate Director Human Resources
Saagar Chitale
Director, Corporate Development And Strategy
Bushra Qureshi
Senior Medical Director, Clinical Development
Roger Garceau
Director
Brian Desch
Director Clinical Operations
Company overview
| Headquarters | 345 Park Avenue South, 3rd Floor, New York, NY 10010, US |
| Phone number | +16468440337 |
| Website | |
| NAICS | 541714 |
| SIC | 283 |
| Keywords | Corporate Development, Rare Diseases, Drug Development, Orphan Diseases, Metabolic Diseases, Parenteral Nutrition, Gastrointestinal Diseases, Choline Deficiency, Short Bowel Syndrome, Non-Muscle Invasive Bladder Cancer, Lymphatic Malformations |
| Founded | 2017 |
| Employees | 21-50 |
| Socials |
Protara Therapeutics Email Formats
Protara Therapeutics uses 3 email formats. The most common is {first initial}.{last name} (e.g., j.doe@protaratx.com), used 51.3% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}.{last name} | j.doe@protaratx.com | 51.3% |
{first name}.{last name} | john.doe@protaratx.com | 46.2% |
{last name}.{last name} | doe.doe@protaratx.com | 2.6% |
About Protara Therapeutics
Protara is committed to advancing transformative therapies for people with cancer and rare diseases. Protara’s portfolio includes its lead program, TARA-002, an investigational cell therapy in development for the treatment of non-muscle invasive bladder cancer and lymphatic malformations, and IV Choline Chloride, an investigational, intravenous phospholipid substrate replacement therapy in development for the treatment of intestinal failure-associated liver disease. For more information, visit www.protaratx.com.
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
Protara Therapeutics has 24 employees across 12 departments.
Departments
Number of employees
Funding Data
Explore Protara Therapeutics's funding history, including investment rounds, total capital raised, and key backers.
Protara Therapeutics Tech Stack
Discover the technologies and tools that power Protara Therapeutics's digital infrastructure, from frameworks to analytics platforms.
Security
WordPress themes
Caching
JavaScript libraries
Page builders
JavaScript libraries
JavaScript libraries
Webmail
Programming languages
Security
Blogs
Portugal
Australia
United Arab Emirates
United KingdomFrequently asked questions
4.8
40,000 users
